The UAE’s higher education market is growing fastest where local study meets international ambition, and Thumbay’s 3+3 medical pathway is built directly around that shift.
Dubai’s private higher education system enrolled 42,026 students in the 2024/25 academic year, up 20.4 percent in twelve months, while international student enrolment climbed 29.4 percent. Health and medicine was one of the fastest-growing fields, with student numbers up 27 percent year on year, according to the latest higher education data published in Dubai. Those three numbers describe a market that is becoming more local and more international at the same time. The UAE is no longer simply an origin market from which students leave for overseas universities. It is increasingly a place where international education begins, even when the degree, clinical experience or final qualification is ultimately delivered somewhere else.
Six years no longer have to happen in one country
Medicine makes that change particularly significant because the conventional decision has been unusually binary: enrol in a complete medical programme at home, or move abroad at the beginning and stay there for most of the degree. Gulf Medical University in Ajman is trying to split that decision in two. For its 2026 intake, the Thumbay International Pathway starts at approximately ₹16 lakh a year with instalment options, according to the university’s latest programme announcement. Students complete three years of pre-clinical education at GMU before progressing, subject to the programme requirements, to three years of clinical study at a partner university. Current destinations include Poland, Romania, Malta, Italy, the United Kingdom, Malaysia, Ghana and Uzbekistan, and the final medical degree is awarded by the partner institution rather than GMU.
That first three-year stage has a regulatory identity of its own. GMU’s Higher Diploma in Preclinical Sciences is listed as an active programme by the UAE’s Commission for Academic Accreditation. Students who successfully meet the prescribed academic and progression requirements can move to the relevant partner without an additional entrance examination at the progression point. In practical terms, the model lets a family postpone the full overseas move until the clinical half of medical education, rather than asking an 18-year-old to combine the transition into medicine with the transition into another country on the same day.
A pathway becomes more convincing after the first graduates
The more important evidence is not the number of destinations but the amount of history behind the model. Thumbay’s pathway began in 2017 with 27 students. More than 650 students from 62 nationalities have enrolled since launch, according to Gulf Medical University’s account of the programme’s first decade, while 335 students from more than 45 nationalities are now enrolled across the three pre-clinical years in Ajman. The longest-running route, with the Medical University of Lublin in Poland, has reached its tenth cohort and produced 90 medical graduates, giving the pathway something newer articulation agreements cannot immediately manufacture: a completed record of students actually moving from Ajman into clinical education and through to a medical degree.
GMU Chancellor Prof. Manda Venkataramana put the value of that record plainly in June: “What this pathway gives them is an honest, direct route from Ajman to a European medical degree, with no guesswork and no closed doors.” That is also why the model fits the UAE’s wider higher education trajectory. Internationalisation is increasingly taking place inside the country rather than only through student departure, while universities compete on the mobility they can preserve after enrolment. For medical education, where curriculum sequencing and clinical placements make mobility harder than in most disciplines, establishing a functioning hand-off between institutions becomes part of the product itself.
The price tag is a starting point, not the whole calculation
There is one boundary families should keep firmly in view. The approximately ₹16 lakh figure is a starting annual fee rather than a guaranteed all-in price for a six-year medical education, and completing the GMU stage does not by itself award an MD. Clinical-stage tuition, living costs, progression rules, capacity, partner-university requirements and later professional licensing depend on the destination. Thumbay’s own published terms state that progression remains subject to successful completion of academic requirements, eligibility, regulatory approvals, available capacity and the admission policies of the relevant institutions.
That qualification does not erase the attraction of the model. It makes the real proposition clearer. As the UAE’s health and medicine enrolment expands, competition will increasingly turn on whether a university can give students both a credible local beginning and a visible international next step. The old question was whether to study medicine in the UAE or abroad. The emerging market is making room for a third answer: start here, move when the clinical stage begins, and know where the route is intended to lead before year one starts.
